<DOC>
	<DOCNO>NCT00001685</DOCNO>
	<brief_summary>This study melanoma tumor antigen peptide vaccine . Peptides represent HLA-A201 restrict T cell epitopes melanoma antigen , MART-1 , gp100 tyrosinase administer emulsified Incomplete Freund 's Adjuvant , ( IFA ) HLA-A201 patient melanoma . The study design evaluate potential therapeutic role , immunologic effect toxicity repeat dos peptide vaccine administer subcutaneously . Immune reactivity peptide epitope monitor patient analysis melanoma-specific T cell precursor prior immunization .</brief_summary>
	<brief_title>Immunization HLA-A201 Patients With Metastatic Melanoma Using Combination Immunodominant Peptides From Three Melanoma Antigens , MART-1 , GP100 Tyrosinase</brief_title>
	<detailed_description>This study melanoma tumor antigen peptide vaccine . Peptides represent HLA-A201 restrict T cell epitopes melanoma antigen , MART-1 , gp100 tyrosinase administer emulsified Incomplete Freund 's Adjuvant , ( IFA ) HLA-A201 patient melanoma . The study design evaluate potential therapeutic role , immunologic effect toxicity repeat dos peptide vaccine administer subcutaneously . Immune reactivity peptide epitope monitor patient analysis melanoma-specific T cell precursor prior immunization .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Any patient 16 year age old measurable metastatic melanoma fail standard treatment expect survival great three month . Must HLAA0201 . Serum creatinine 2.0 mg/dl less . Bilirubin 1.6 mg/dl less . WBC 3000/mm ( 3 ) great . Platelet count 90,000 mm ( 3 ) great . Serum AST/ALT less two time normal . ECOG performance status 0 1 . Patients gender must willing practice effective birth control trial . Must undergo undergone past 3 week form therapy except surgery cancer . Must active systemic infection , coagulation disorder , major medical illness cardiovascular respiratory system know immunodeficiency disease . Must require steroid therapy . Must pregnant . Must positive hepatitis B ( ) AG HIV antibody . Must know allergic reaction Incomplete Freund 's Adjuvant ( IFA ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1999</verification_date>
	<keyword>Cancer</keyword>
	<keyword>IL-12</keyword>
	<keyword>IL-2</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Vaccine</keyword>
</DOC>